December 19th 2019EP. 1: Transplant Eligibility, NCCN Recommendations, and Sequencing
December 19th 2019EP. 2: Proteasome Inhibitor-Based Treatment Regimens
December 19th 2019EP. 3: Treatment of Newly Diagnosed Symptomatic Myeloma and Dosing Regimens
December 19th 2019EP. 4: Studies With a PI-Based Quadruplet Regimen and Sequencing
December 19th 2019EP. 5: MRD Assessment and Prognostic Factors for Myeloma
December 19th 2019EP. 6: Maintenance Therapy and Relapse/Refractory Treatment
December 19th 2019EP. 7: Unmet Needs and the Future of Myeloma
